InvestorsHub Logo

Chabojilo

02/22/14 9:41 AM

#25505 RE: zumantu #25501

I know, this is where it hurts, FDA demanding REDUCE-IT while denying exclusivity. Yeah, they have patents, but they really should not have to worry about ANDAs while trying to complete this study. FDA has been the biggest pain in the you know what to this company.

Biobillionair

02/22/14 10:08 AM

#25510 RE: zumantu #25501

It might be time to ally with new 10% holder and flush management and BOD out the door. Do you remember what our EPADI shareholder count was?